Objective:To prepare the Huangyangning osmotic pump controlled release tablet.
前言： 目的：以黄杨宁为模型药物制备黄杨宁渗透泵控释片。
The invention provides a doxazosin mesylate bi-layer osmotic pump controlled release tablet.
本发明提供了一种甲磺酸多沙唑嗪双层渗透泵控释片。
OBJECTIVE: to prepare diclofenac sodium controlled release tablet, and to evaluate the mechanism of drug release.
目的：制备双氯芬酸钠控释片，并对其药物释放机制进行了研究。
AIM: To observe the influence of nifedipine controlled release tablet on insulin resistance (IR) in elderly patients with hypertension.
目的：了解硝苯地平控释片对老年高血压病人的胰岛素抵抗(IR)的影响。
The technology of the invention can ensure that the prepared two-layer osmotic pump controlled release tablet has good bioavailability.
该技术可以确保制备的双层渗透泵控释片具有良好的生物利用度。
CONCLUSION: To elderly patients with hypertension, nifedipine controlled release tablet can not only decease blood pressure but also improve IR.
结论：硝苯地平控释片治疗老年高血压病人不仅降压效果确切，而且能改善病人的IR。
The invention relates to the drug preparation field, in particular to a two-layer osmotic pump controlled release tablet preparation and a preparation method thereof.
本发明涉及药物制剂领域，具体涉及双层渗透泵控释片制剂及其制备方法。
ConclusionCamellia saponin controlled-release tablet can be prepared when powder of cornstalk and HPMC are used as excipients of troches.
结论以玉米秆粉末和羟丙甲基纤维素作为片剂辅料，可制备油茶皂苷控释片。
ObjectiveTo prepare camellia saponin controlled-release tablet and investigate the technology conditions of preparation tablet.
目的制备油茶皂苷控释片，考察制备工艺条件。
MethodsPower of cornstalk and hydroxypropyl methylcellulose (HPMC) were used as excipients to prepare camellia saponin controlled-release tablet.
方法以玉米秆粉末和羟丙甲基纤维素作为片剂辅料，制备油茶皂苷控释片。
The stability of camellia saponin controlled-release tablet was good.
该油茶皂苷控释片的稳定性良好。
The invention also discloses a danshinolic acid B enteric controlled-release tablet preparation and a preparation method thereof.
本发明还公开了一种上述丹酚酸B肠溶控释片制剂及 其制备方法。
The stability of camellia saponin controlled-release tablet was also investigated.
研究该油茶皂苷控释片的稳定性。
The stability of camellia saponin controlled-release tablet was also investigated.
研究该油茶皂苷控释片的稳定性。
应用推荐